# The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group

> **NCT00617474** · PHASE1 · UNKNOWN · sponsor: **Labbafinejhad Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Transplantation, Kidney

## Interventions

- **DRUG:** Erythropoietin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00617474
- **Lead sponsor:** Labbafinejhad Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2008-09
- **Final completion:** 2009-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2008-03-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00617474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00617474, "The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00617474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*